title: Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavir.
authors: aKing's College Hospital NHS Foundation Trust bKing's College London School of Medicine, London, UK.
authors: Lisa
authors: L
authors: Hamzah
authors: Lucy
authors: L
authors: Campbell
authors: Emily
authors: E
authors: Wandolo
authors: Birgit
authors: B
authors: Engler
authors: Emily
authors: E
authors: Cheserem
authors: Claire
authors: C
authors: Naftalin
authors: Chris
authors: C
authors: Taylor
authors: Frank A
authors: FA
authors: Post
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000069446:Atazanavir Sulfate; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000502:physiology*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate; D019438:Ritonavir